shot-button
Ganesh Chaturthi Ganesh Chaturthi
Home > News > India News > Article > Will supply Covid 19 vaccines only to central govts discussion with GOI underway Pfizer

Will supply Covid-19 vaccines only to central govts, discussion with GOI underway: Pfizer

Updated on: 24 May,2021 12:00 AM IST  |  New Delhi
ANI |

On state procurement tenders, the US vaccine maker said it will supply vaccines only to central governments.

Will supply Covid-19 vaccines only to central govts, discussion with GOI underway: Pfizer

Representational Image | File Pic

To bring Pfizer-BioNTech Covid-19 vaccine for use in India, discussions are underway between the Government of India (GOI) and Pfizer Inc. In a statement on Monday, Pfizer spokesperson said: "Pfizer's discussions with the GOI are ongoing and we are hopeful to bring the Pfizer-BioNTech Covid-19 vaccine for use in the country. We are unable to divulge further details at this moment."


On state procurement tenders, the US vaccine maker said it will supply vaccines only to central governments. "Pfizer will supply Covid-19 vaccine only to central governments and supra-national organisations for deployment in national immunization programs. Allocation of doses and implementation plan within a country is a decision for local governments based on relevant health authority guidance," it said.


Also Read: RDIF, Panacea Biotec to start Sputnik V production in India


Pfizer said that the development, manufacturing, distribution and storage of complex innovative products, including the mRNA technology, requires globally-optimized supply chains. "Since the beginning of this pandemic, Pfizer's priority has been to ensure rapid manufacturing and deployment of the Covid-19 vaccine to cater to the current emergency response scenario.

We have a robust supply chain currently in place with established capabilities - one each in the US and one in Europe - that can quickly manufacture and deploy the vaccine for use across the world," the spokesperson said. Pfizer and BioNTech have set a target to deliver over 2.5 billion vaccine doses in 2021. This includes expanding the manufacturing capabilities and increasing the supplier base for key materials to the supply chain, said the company official.

 

This story has been sourced from a third party syndicated feed, agencies. Mid-day accepts no responsibility or liability for its dependability, trustworthiness, reliability and data of the text. Mid-day management/mid-day.com reserves the sole right to alter, delete or remove (without notice) the content in its absolute discretion for any reason whatsoever

"Exciting news! Mid-day is now on WhatsApp Channels Subscribe today by clicking the link and stay updated with the latest news!" Click here!


Mid-Day Web Stories

Mid-Day Web Stories

This website uses cookie or similar technologies, to enhance your browsing experience and provide personalised recommendations. By continuing to use our website, you agree to our Privacy Policy and Cookie Policy. OK